Menu
Back to Journals » Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment
ISSN: 1178-2021
- View all (3968)
- Volume 19, 2023 (111)
- Volume 18, 2022 (272)
- Volume 17, 2021 (351)
- Volume 16, 2020 (325)
- Volume 15, 2019 (353)
- Volume 14, 2018 (354)
- Volume 13, 2017 (333)
- Volume 12, 2016 (367)
- Volume 11, 2015 (340)
- Volume 10, 2014 (275)
- Volume 9, 2013 (223)
- Volume 8, 2012 (74)
- Volume 7, 2011 (87)
- Volume 6, 2010 (90)
- Volume 5, 2009 (65)
- Volume 4, 2008 (128)
- Volume 3, 2007 (105)
- Volume 2, 2006 (70)
- Volume 1, 2005 (45)
Journal Articles:
- 3,968 records -
Spontaneous Changes in Attentional Capabilities and Reasoning After an Alcohol Rehabilitation Treatment: Evidence About the Role of Age and Alcohol Use
Fiabane E, Scarpina F, Ottonello M, Pistarini C
Neuropsychiatric Disease and Treatment 2023, 19:1321-1329
Published Date: 31 May 2023
Prevalence and Risk Factors of Anxiety Among Adult Patients with Chronic Pharyngitis in Wuhu, China
Zha Z, Gao S, Liu S, Hu G
Neuropsychiatric Disease and Treatment 2023, 19:1313-1319
Published Date: 31 May 2023
Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
Heim B, Peball M, Krismer F, Djamshidian A, Seppi K
Neuropsychiatric Disease and Treatment 2023, 19:1303-1312
Published Date: 30 May 2023
Electrocardiogram Abnormalities and Associated Factors Among People with and without Epilepsy Attending the Outpatient Department at Referral Hospitals in Amhara Regional State, Northern Ethiopia, 2022: Institutional-Based Comparative Cross-Sectional Study
Adane T, Melese M, Tesfaye E, Ambelu A, Getnet M, Sinamaw D, Esubalew D, Yismaw Y
Neuropsychiatric Disease and Treatment 2023, 19:1285-1302
Published Date: 30 May 2023
Efficacy of Scalp Acupuncture with the Long-Stay Method on Motor Dysfunction in Patients with Acute Ischemic Stroke: A Randomized Controlled Trial
Wang H, Guo J, Zhang Y, Fang J, Qiu S, He Y, Fan L, Lei X
Neuropsychiatric Disease and Treatment 2023, 19:1273-1283
Published Date: 30 May 2023
The Efficacy and Cognitive Impact of Perampanel Monotherapy in Patients with Self-Limited Epilepsy with Centrotemporal Spikes: A Retrospective Analysis
Yue X, Liu XM, Chen J, Chen HY, Tan QQ, Zhou Y
Neuropsychiatric Disease and Treatment 2023, 19:1263-1271
Published Date: 29 May 2023
Exercise-Induced Autophagy Ameliorates Motor Symptoms Progressivity in Parkinson’s Disease Through Alpha-Synuclein Degradation: A Review
Goenawan H, Kiasati S, Sylviana N, Megantara I, Lesmana R
Neuropsychiatric Disease and Treatment 2023, 19:1253-1262
Published Date: 25 May 2023
CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG [Corrigendum]
Simfukwe C, Youn YC, Kim MJ, Paik J, Han SH
Neuropsychiatric Disease and Treatment 2023, 19:1251-1252
Published Date: 24 May 2023
Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
Gagliano A, Carta A, Tanca MG, Sotgiu S
Neuropsychiatric Disease and Treatment 2023, 19:1221-1250
Published Date: 24 May 2023
Network Analysis of ADHD Symptoms and Cognitive Profiles in Children
Zhou Q, Ye X, Wei C, Wu Y, Ren P, Lin X, Li L, Xiang W, Xiao L
Neuropsychiatric Disease and Treatment 2023, 19:1207-1219
Published Date: 18 May 2023
Automatic Thoughts, Self-Stigma, and Resilience Among Schizophrenia Patients with Metabolic Syndrome: A Cross-Sectional Study
Ma S, Ju P, Xia Q, Pan Z, Gao J, Zhang L, Gao H, Yan J, Zhang J, Wang K, Li C, Xie W, Zhu C
Neuropsychiatric Disease and Treatment 2023, 19:1195-1206
Published Date: 17 May 2023
Long-Term Treatment with Trazodone Once-A-Day (TzOAD) in Patients with MDD: An Observational, Prospective Study
Shrashimirova M, Tyanev I, Cubała WJ, Wichniak A, Vodickova-Borzova C, Ruggieri A, Bonelli A, Lipone P, Comandini A, Cattaneo A
Neuropsychiatric Disease and Treatment 2023, 19:1181-1193
Published Date: 12 May 2023
Clinical Features, Brain-Structure Changes, and Cognitive Impairment in Basal Ganglia Infarcts: A Pilot Study
Zuo L, Dong Y, Hu Y, Xiang X, Liu T, Zhou J, Shi J, Wang Y
Neuropsychiatric Disease and Treatment 2023, 19:1171-1180
Published Date: 11 May 2023
Transcription Factor E2F1 Aggravates Neurological Injury in Ischemic Stroke via microRNA-122-Targeted Sprouty2 [Retraction]
Wu Y, Gao Z, Zhang J
Neuropsychiatric Disease and Treatment 2023, 19:1169-1170
Published Date: 11 May 2023
Psychopathological Dissection of Bipolar Disorder and ADHD: Focussing on Racing Thoughts and Verbal Fluency
Bertschy G, Martz E, Weibel S, Weiner L
Neuropsychiatric Disease and Treatment 2023, 19:1153-1168
Published Date: 11 May 2023
Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
Kidambi N, Elsayed OH, El-Mallakh RS
Neuropsychiatric Disease and Treatment 2023, 19:1145-1151
Published Date: 10 May 2023
Comparison of Noninvasive Measurements of Intracranial with Tap Test Results in Patients with Idiopathic Normal Pressure Hydrocephalus
Mendes GAS, Hayashi CY, Vilela GHF, Kido L, Teixeira MJ, Pinto FCG
Neuropsychiatric Disease and Treatment 2023, 19:1127-1143
Published Date: 9 May 2023
Serum Cystatin C is Associated with Depression After Intracerebral Hemorrhage
Zhu L, Yu C, Chang Y, Sun S, Sun Z
Neuropsychiatric Disease and Treatment 2023, 19:1117-1126
Published Date: 8 May 2023
Hemodynamic Changes in Patients with Chronic Internal Carotid Artery Occlusion After Recanalization
Xiao C, Chen X, Lu L, Ye Z, Chen X, Dong M, Qin C
Neuropsychiatric Disease and Treatment 2023, 19:1103-1115
Published Date: 3 May 2023
The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation
Haley CL, Kennard BD, Morris DW, Bernstein IH, Carmody T, Emslie GJ, Mayes TL, Rush AJ
Neuropsychiatric Disease and Treatment 2023, 19:1085-1102
Published Date: 2 May 2023
Acupuncture for Major Depressive Disorder: A Data Mining-Based Literature Study
Tu M, Xiong S, Lv S, Wu X, Hu H, Hu R, Fang J, Shao X
Neuropsychiatric Disease and Treatment 2023, 19:1069-1084
Published Date: 2 May 2023
The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan
Kato M, Tsuda H, Chen Y, Tsuji T, Nishigaki N
Neuropsychiatric Disease and Treatment 2023, 19:1055-1067
Published Date: 1 May 2023
Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis
Wang X, Zhu X, Ji X, Yang J, Zhou J
Neuropsychiatric Disease and Treatment 2023, 19:1043-1053
Published Date: 1 May 2023
Elevated Serum NOX2 Levels Contribute to Delayed Cerebral Ischemia and a Poor Prognosis After Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study
Wu X, Ji D, Wang Z, Yu W, Du Q, Hu W, Zheng Y, Dong X, Chen F
Neuropsychiatric Disease and Treatment 2023, 19:1027-1042
Published Date: 29 April 2023
Effect of Repeated Intranasal Administration of Different Doses of Insulin on Postoperative Delirium, Serum τ and Aβ Protein in Elderly Patients Undergoing Radical Esophageal Cancer Surgery
Huang Q, Shi Q, Yi X, Zeng J, Dai X, Lin L, Yang Y, Wu X, Gong G
Neuropsychiatric Disease and Treatment 2023, 19:1017-1026
Published Date: 28 April 2023
Frequency and Risk Factors of Subsyndromal Delirium in the Intensive Care Units: A Prospective Cohort Study
Gao Y, Gong S, Zhou W, Li X, Gan X
Neuropsychiatric Disease and Treatment 2023, 19:1003-1016
Published Date: 28 April 2023
Bibliometric Analysis of Research Themes and Trends of the Co-Occurrence of Autism and ADHD
Liu A, Lu Y, Gong C, Sun J, Wang B, Jiang Z
Neuropsychiatric Disease and Treatment 2023, 19:985-1002
Published Date: 24 April 2023
Diagnosis of Epilepsy by Traditional Healers and Its Implications on Management in the Selected Rural Communities of Limpopo and Mpumalanga Provinces: A Qualitative Study
Nemathaga M, Maputle MS, Makhado L, Mashau NS
Neuropsychiatric Disease and Treatment 2023, 19:973-983
Published Date: 18 April 2023
Acupuncture Ameliorated Behavioral Abnormalities in the Autism Rat Model via Pathways for Hippocampal Serotonin
Chen S, Huang L, Liu G, Kang J, Qian Q, Wang J, Wang R, Zheng L, Wang H, Ou P
Neuropsychiatric Disease and Treatment 2023, 19:951-972
Published Date: 18 April 2023
Associations Between Internet Addiction, Psychiatric Comorbidity, and Maternal Depression and Anxiety: Potential Underlying Mechanisms [Response to Letter]
Sakamoto S, Miyawaki D, Goto A, Hirai K, Hama H, Kadono S, Nishiura S, Inoue K
Neuropsychiatric Disease and Treatment 2023, 19:949-950
Published Date: 18 April 2023
Oxytocin and Women Postpartum Depression: A Systematic Review of Randomized Controlled Trials
Zhu J, Jin J, Tang J
Neuropsychiatric Disease and Treatment 2023, 19:939-947
Published Date: 18 April 2023
Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
Wang Z, Zheng Y, Fan Y, Fan Y, Su X, Wang B, Li J, Chen D, Sun F, Li S, Ma J, Li X, Bai L, Li R
Neuropsychiatric Disease and Treatment 2023, 19:929-938
Published Date: 17 April 2023
Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years
Yasui-Furukori N, Kawamata Y, Sasaki T, Yokoyama S, Okayasu H, Shinozaki M, Takeuchi Y, Sato A, Ishikawa T, Komahashi-Sasaki H, Miyazaki K, Fukasawa T, Furukori H, Sugawara N, Shimoda K
Neuropsychiatric Disease and Treatment 2023, 19:921-928
Published Date: 17 April 2023
Transcutaneous Electrical Acupoint Stimulation for Preventing Postoperative Delirium: A Meta-Analysis
Guo F, Yan Y, Sun L, Han R, Zheng L, Qin Y, Wang S, Sun X, Ji Z, Gao C
Neuropsychiatric Disease and Treatment 2023, 19:907-920
Published Date: 15 April 2023
Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
Giron‐Hernandez C, Han JH, Alberio R, Singh A, García-Portilla MP, Pompili M, Knight RK, Richarz U, Gopal S, Antunes J
Neuropsychiatric Disease and Treatment 2023, 19:895-906
Published Date: 13 April 2023
Nomogram-Based Prediction of the Futile Recanalization Risk Among Acute Ischemic Stroke Patients Before and After Endovascular Therapy: A Retrospective Study
Guan J, Wang Q, Hu J, Hu Y, Lan Q, Xiao G, Zhou B, Guan H
Neuropsychiatric Disease and Treatment 2023, 19:879-894
Published Date: 13 April 2023
Garden Cress (Lepidium sativum) Seeds Ameliorated Aluminum-Induced Alzheimer Disease in Rats Through Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects
Balgoon MJ
Neuropsychiatric Disease and Treatment 2023, 19:865-878
Published Date: 12 April 2023
CNN for a Regression Machine Learning Algorithm for Predicting Cognitive Impairment Using qEEG
Simfukwe C, Youn YC, Kim MJ, Paik J, Han SH
Neuropsychiatric Disease and Treatment 2023, 19:851-863
Published Date: 12 April 2023
Pathology and Astrocytes in Autism
Vakilzadeh G, Martinez-Cerdeño V
Neuropsychiatric Disease and Treatment 2023, 19:841-850
Published Date: 12 April 2023
Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
Zhu Y, Wu Z, Zhao D, Wu X, He R, Wang Z, Peng D, Fang Y
Neuropsychiatric Disease and Treatment 2023, 19:829-839
Published Date: 12 April 2023
Targeting the Arginine Vasopressin V1b Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders
Kanes SJ, Dennie L, Perera P
Neuropsychiatric Disease and Treatment 2023, 19:811-828
Published Date: 12 April 2023
Correlation Between Aggressive Behavior and Impulsive and Aggressive Personality Traits in Stable Patients with Schizophrenia
Gao L, Yang R, Fan HZ, Wang LL, Zhao YL, Tan SP, Xiao CL, Zhou SJ
Neuropsychiatric Disease and Treatment 2023, 19:801-809
Published Date: 12 April 2023
Vitamin B12, Folate, Homocysteine, Inflammatory Mediators (Interleukin-6, Tumor Necrosis Factor-α and C-Reactive Protein) Levels in Adolescents with Anxiety or Depressive Symptoms
Tan Y, Zhou L, Huang J, Chen X, Wu Y, Song X, Wang J, Hu H, Yang Q
Neuropsychiatric Disease and Treatment 2023, 19:785-800
Published Date: 7 April 2023
Recombinant Adenovirus-Mediated HIF-lα Ameliorates Neurological Dysfunction by Improving Energy Metabolism in Ischemic Penumbra After Cerebral Ischemia-Reperfusion in Rats
Zhou W, Tao T, Yu W, Wu W, Hui Z, Xu H, Li Y, Zhang Y, Yang X
Neuropsychiatric Disease and Treatment 2023, 19:775-784
Published Date: 6 April 2023
Associations Between Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Traits and Sociodemographic Characteristics in Japanese Workers
Suzuki T, Wada K, Nakazato M, Ohtani T, Yamazaki M, Ikeda S
Neuropsychiatric Disease and Treatment 2023, 19:759-773
Published Date: 5 April 2023
Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety
Zhao M, Qin B, Mao Y, Zhang Y, Zhao R, Wang A, Wang H, Zhao J, Wang C
Neuropsychiatric Disease and Treatment 2023, 19:749-757
Published Date: 5 April 2023
Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions
Singh A, Hadjinicolaou A, Peters JM, Salussolia CL
Neuropsychiatric Disease and Treatment 2023, 19:733-748
Published Date: 5 April 2023
Use of Selective Alternative Therapies for Treatment of OCD
Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A
Neuropsychiatric Disease and Treatment 2023, 19:721-732
Published Date: 5 April 2023
The Relationship Between Neuron-Specific Enolase and Clinical Outcomes in Patients Undergoing Mechanical Thrombectomy
Peng Q, Chen W, E Y, Deng Y, Xu Z, Wang S, Fu X, Wei B, Wang M, Hou J, Zhang Y, Duan R
Neuropsychiatric Disease and Treatment 2023, 19:709-719
Published Date: 4 April 2023
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
Chen X, Hou X, Bai D, Lane R, Zhang C, Canuso C, Wang G, Fu DJ
Neuropsychiatric Disease and Treatment 2023, 19:693-707
Published Date: 31 March 2023